A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease.
about
Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2Global analysis of cdc14 dephosphorylation sites reveals essential regulatory role in mitosis and cytokinesisIntegrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity.Quantitative proteomic analysis of human lung tumor xenografts treated with the ectopic ATP synthase inhibitor citreoviridinTemporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition?Identification of in vivo phosphorylation sites of lens proteins from porcine eye lenses by a gel-free phosphoproteomics approachInterplay between SIN3A and STAT3 mediates chromatin conformational changes and GFAP expression during cellular differentiationPlasma membrane proteomics and its application in clinical cancer biomarker discovery.Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly.Complementary Fe(3+)- and Ti(4+)-immobilized metal ion affinity chromatography for purification of acidic and basic phosphopeptides.Organelle membrane proteomics reveals differential influence of mycobacterial lipoglycans on macrophage phagosome maturation and autophagosome accumulation.Phosphoproteomics characterization of novel phosphorylated sites of lens proteins from normal and cataractous human eye lensesMembrane proteins and membrane proteomics.An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signalingInteraction of peroxiredoxin V with dihydrolipoamide branched chain transacylase E2 (DBT) in mouse kidney under hypoxia.Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells.Proteomics and opportunities for clinical translation in urological disease.Gel-aided sample preparation (GASP)--a simplified method for gel-assisted proteomic sample generation from protein extracts and intact cellsMultiplex IP-FCM (immunoprecipitation-flow cytometry): Principles and guidelines for assessing physiologic protein-protein interactions in multiprotein complexes.In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disordersMitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLCMining Missing Membrane Proteins by High-pH Reverse-Phase StageTip Fractionation and Multiple Reaction Monitoring Mass Spectrometry.Analysis of the immune response of human dendritic cells to Mycobacterium tuberculosis by quantitative proteomics.Comparative proteomics analysis of degenerative eye lenses of nocturnal rice eel and catfish as compared to diurnal zebrafishMicroRNA-122 influences the development of sperm abnormalities from human induced pluripotent stem cells by regulating TNP2 expression.Quantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophyMass spectrometry-based analysis of rat liver and hepatocellular carcinoma Morris hepatoma 7777 plasma membrane proteomeThematic review series: proteomics. Proteomic analysis of lipid-protein complexes.An approach to characterize the membrane proteome of Candida albicans.Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer.Proteomics in China: ready for prime time.Urinary exosomes and proteomics.Mass spectrometry accelerates membrane protein analysis.Mammalian plasma membrane proteins as potential biomarkers and drug targets.Label-free mass spectrometry-based proteomics for biomarker discovery and validation.Current approaches and challenges in targeted absolute quantification of membrane proteins.An integrated proteomic and transcriptomic approach to understanding azathioprine- induced hepatotoxicity in rat primary hepatocytes.Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.
P2860
Q24337403-2A91B4E3-1767-4A80-9C3B-97893B70A4A0Q27939709-5C83F49A-3962-4AC1-9926-14D18CE34461Q30586189-3765518F-9A5F-48D3-8285-1726B00722D4Q31130853-08AC4AAF-0884-4F49-B671-4EC1B9D790FDQ33384709-7A7AD763-40AA-4416-81B4-D5EF56250DC0Q33682950-E8AB6BCF-D254-447C-AFFC-BCCF98231898Q33968201-E895D219-7E42-4567-A5A2-A318116CD7C1Q34122107-229DCE71-EAC4-4DA8-BA35-34E6F274A1A1Q34122163-02A7F350-EED2-42DF-8C4C-7416F547B483Q34377453-210D5D94-A98D-42F0-BB41-30F431A72260Q34477748-D385D6A5-DCE4-4433-92BF-6FF0CDEFD868Q34511275-16F48261-D30B-44AD-BB4C-FDBD0C1416FAQ34657071-FA03CB57-61B5-4EB6-9B8B-17F6C062C038Q34751614-37CFC67F-77A1-461A-9D10-287D7B18F74FQ34958402-E527282E-BB8A-406B-B049-C8FD39E2C37EQ35068160-D1B46843-3744-4C2B-8E98-AFFABB605E52Q35083386-CE31A648-2AD2-4197-ABF3-22A5CCB29B2BQ35207579-17CFC33B-427F-4180-9B62-EF9EFF04EDF9Q35525310-99F37890-8FD4-4900-8DFF-AE976FF1E40FQ35680900-1F5B7124-4B30-43A5-A69B-A6363CCB5984Q35722244-36E64CAE-08F7-46E5-B5DD-C1C6CE0DAEB7Q35951700-1AA00E0D-6DFE-49B2-8E13-04D57549D91BQ36545739-A59A344D-7BDC-460D-88DA-69157D8B31DFQ36600047-CB042974-29D8-44CB-8E87-D90556AC36ABQ36662464-33160991-EC0F-4368-8FA0-6268E857BD7AQ36727735-A5E81746-F303-417C-A350-FFF3BB6BB652Q36889862-69779105-2B1E-4DE4-9E6B-23FC5A5DB456Q37289370-59824EBA-2C99-4A26-A30C-002D2D17B952Q37343333-934C0A5B-0AA5-4742-921C-E525027AC04EQ37396753-F5FD028F-4360-4E31-8EE7-4F58155B4A2BQ37689704-34744C60-BB56-46CA-8ED1-008BB593D8AFQ37698720-C2E98EF6-5C84-4C35-A5DC-44F22AFD73D6Q37769478-1B2B0F14-F029-4F8A-B2EB-3EE9D7B9F08BQ37872261-313DC09D-7C6C-4A2D-A9C4-DD22AF578331Q37880456-D3B30AB8-10E6-49F9-BF9E-A531D7508AE4Q37894617-E985AB77-EB3D-46CF-833C-0BA46A53C575Q38012172-6D7FE26D-DB0C-4D8E-8891-A54C4AC5512BQ38285772-EBA040F9-1BEF-432A-A8FE-65C84E7BFBA8Q38443595-51CBEA62-997C-450C-A541-007EB674E39EQ38456584-02F199CA-334D-4BB8-BDD3-B86A0808BB84
P2860
A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A multiplexed quantitative str ...... ant polycystic kidney disease.
@en
A multiplexed quantitative str ...... ant polycystic kidney disease.
@nl
type
label
A multiplexed quantitative str ...... ant polycystic kidney disease.
@en
A multiplexed quantitative str ...... ant polycystic kidney disease.
@nl
prefLabel
A multiplexed quantitative str ...... ant polycystic kidney disease.
@en
A multiplexed quantitative str ...... ant polycystic kidney disease.
@nl
P2093
P2860
P1476
A multiplexed quantitative str ...... ant polycystic kidney disease.
@en
P2093
Chia-Li Han
Chien-Peng Wu
Chih-Wei Chien
Wen-Cheng Chen
Yet-Ran Chen
Yu-Ju Chen
P2860
P304
P356
10.1074/MCP.M800068-MCP200
P577
2008-05-18T00:00:00Z